These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 11405650)
1. Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor. Lee CH; Jiang M; Cowart M; Gfesser G; Perner R; Kim KH; Gu YG; Williams M; Jarvis MF; Kowaluk EA; Stewart AO; Bhagwat SS J Med Chem; 2001 Jun; 44(13):2133-8. PubMed ID: 11405650 [TBL] [Abstract][Full Text] [Related]
2. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat. Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454 [TBL] [Abstract][Full Text] [Related]
3. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse. Jarvis MF; Yu H; Kohlhaas K; Alexander K; Lee CH; Jiang M; Bhagwat SS; Williams M; Kowaluk EA J Pharmacol Exp Ther; 2000 Dec; 295(3):1156-64. PubMed ID: 11082453 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and structure-activity relationship of 6-alkynylpyrimidines as potent adenosine kinase inhibitors. Gomtsyan A; Didomenico S; Lee CH; Matulenko MA; Kim K; Kowaluk EA; Wismer CT; Mikusa J; Yu H; Kohlhaas K; Jarvis MF; Bhagwat SS J Med Chem; 2002 Aug; 45(17):3639-48. PubMed ID: 12166937 [TBL] [Abstract][Full Text] [Related]
5. Recent developments in the discovery of novel adenosine kinase inhibitors: mechanism of action and therapeutic potential. McGaraughty S; Cowart M; Jarvis MF CNS Drug Rev; 2001; 7(4):415-32. PubMed ID: 11830758 [TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis. Boyle DL; Kowaluk EA; Jarvis MF; Lee CH; Bhagwat SS; Williams M; Firestein GS J Pharmacol Exp Ther; 2001 Feb; 296(2):495-500. PubMed ID: 11160636 [TBL] [Abstract][Full Text] [Related]
7. Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor. Jarvis MF; Yu H; McGaraughty S; Wismer CT; Mikusa J; Zhu C; Chu K; Kohlhaas K; Cowart M; Lee CH; Stewart AO; Cox BF; Polakowski J; Kowaluk EA Pain; 2002 Mar; 96(1-2):107-18. PubMed ID: 11932067 [TBL] [Abstract][Full Text] [Related]
8. 4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitors. Matulenko MA; Paight ES; Frey RR; Gomtsyan A; DiDomenico S; Jiang M; Lee CH; Stewart AO; Yu H; Kohlhaas KL; Alexander KM; McGaraughty S; Mikusa J; Marsh KC; Muchmore SW; Jakob CL; Kowaluk EA; Jarvis MF; Bhagwat SS Bioorg Med Chem; 2007 Feb; 15(4):1586-605. PubMed ID: 17197188 [TBL] [Abstract][Full Text] [Related]
10. 5-(3-Bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-ylamine: structure-activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors. Matulenko MA; Lee CH; Jiang M; Frey RR; Cowart MD; Bayburt EK; Didomenico S; Gfesser GA; Gomtsyan A; Zheng GZ; McKie JA; Stewart AO; Yu H; Kohlhaas KL; Alexander KM; McGaraughty S; Wismer CT; Mikusa J; Marsh KC; Snyder RD; Diehl MS; Kowaluk EA; Jarvis MF; Bhagwat SS Bioorg Med Chem; 2005 Jun; 13(11):3705-20. PubMed ID: 15863000 [TBL] [Abstract][Full Text] [Related]
11. The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury. Suzuki R; Stanfa LC; Kowaluk EA; Williams M; Jarvis MF; Dickenson AH Br J Pharmacol; 2001 Apr; 132(7):1615-23. PubMed ID: 11264257 [TBL] [Abstract][Full Text] [Related]